Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health.
The hope is that insurers will start understanding that this is not a vanity drug.
[
add
]
[
|
|
...
]
Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health.
The hope is that insurers will start understanding that this is not a vanity drug.